KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemed (CHE) Operating Income: 2009-2024

Historic Operating Income for Chemed (CHE) over the last 16 years, with FY2024 value amounting to $366.5 million.

  • Chemed's Operating Income fell 1888.84% to $74.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $351.5 million, marking a year-over-year decrease of 344.47%. This contributed to the annual value of $366.5 million for FY2024, which is 761.2% up from last year.
  • According to the latest figures from FY2024, Chemed's Operating Income is $366.5 million, which was up 761.2% from $340.6 million recorded in FY2023.
  • Over the past 5 years, Chemed's Operating Income peaked at $389.7 million during FY2020, and registered a low of $340.6 million during FY2023.
  • For the 5-year period, Chemed's Operating Income averaged around $356.7 million, with its median value being $343.5 million (2022).
  • Its Operating Income has fluctuated over the past 5 years, first soared by 5140.26% in 2020, then tumbled by 1196.93% in 2021.
  • Chemed's Operating Income (Annual) stood at $389.7 million in 2020, then fell by 11.97% to $343.0 million in 2021, then rose by 0.13% to $343.5 million in 2022, then decreased by 0.85% to $340.6 million in 2023, then rose by 7.61% to $366.5 million in 2024.
  • Its Operating Income stands at $366.5 million for FY2024, versus $340.6 million for FY2023 and $343.5 million for FY2022.